1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
612EFBA297831B1A5852573E7005054D1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/maintaining-a-competitive-edge-in-pharmaceutical-public-affairs-benchmarking-the-resources-required-to-serve-the-us-market?opendocument
18
19opendocument
2054.226.58.177
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services

Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market

ID: PSM-222


Features:

2 Info Graphics

34 Data Graphics

154 Metrics

12 Narratives

7 Best Practices


Pages: 53


Published: Pre-2013


Delivery Format: Shipped


 

License Options:

close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations. This benchmark study was designed to collect key staffing and investment benchmarks for U.S. based pharmaceutical Public Affairs functions. Data from this study will allow U.S. pharmaceutical companies to assess the efficiency of their Public Affairs functions relative to their peers.


For the purposes of this benchmarking exchange, Public Affairs was divided into six work functions:

  • Government Affairs (State and Federal Government Relations and Public Policy)
  • Corporate Communications – External
  • Corporate Communication – Internal
  • Product Communications
  • Corporate Social Responsibility
  • Alliance Management
Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device


Companies Profiled:
Abbott; Astellas Pharma; Boehringer Ingelheim; Cardinal Health; Celgene; Genzyme; LaVoie Group; Medtronic; Nektar Therapeutics; Novartis; Sanofi-Aventis; Shire; UCB; WellStar Health System


Study Snapshot

This research was based on survey results from 17 participants from 15 pharmaceutical and biotechnology companies.

Key topics include:
  • Public Affairs: Structure and Reporting Relationships
  • Public Affairs: Staffing
  • Public Affairs: Investment
  • Public Affairs: Consolidated Staffing and Investment Efficiency Ratios
  • Lessons Learned

Sample Key Findings

Shift in Primary Responsibilities Undertaken by Public Affairs Head: While Government Affairs and Corporate Communication continue to be primary functions overseen by the Public Affairs group; relatively fewer organizations oversee Product Communications and Alliance Management in 2012 (more than 20% less from 2008). On the other hand, Corporate Social Responsibility is overseen by the Public Affairs head at 73% companies in 2012, which is 13% more than in 2008.
  • Significant Increase in Public Affairs Contribution to Multiple Management Teams: As compared to 2008, the number of management teams on which Public Affairs sits has increased dramatically in 2012. For instance, organizations with Public Affairs serving on less than 5 management teams was 93% in 2008. Nowadays, 80 percent of Public Affairs groups serve 6 or more management teams. In fact, 40 percent say they sit on 12 or more management teams in 2012.
Table of Contents

Introduction
  • Summary Of Key Insights
  • Universe Of Learning
  • Public Affairs: Structure And Reporting Relationships
  • Public Affairs: Staffing
  • Public Affairs: Investment
  • Public Affairs: Consolidated Staffing And Investment Efficiency Ratios
  • Lessons Learned - Voices From The Field
  • About Best Practices, LLC